Renaissance Technologies IONIS PHARMACEUTICALS ownership

IONIS PHARMACEUTICALS's ticker is IONS and the CUSIP is 462222100. A total of 341 filers reported holding IONIS PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Renaissance Technologies ownership history of IONIS PHARMACEUTICALS
ValueSharesWeighting
Q3 2022$38,379
+68.6%
867,714
+41.1%
0.05%
+100.0%
Q2 2022$22,760
+355.5%
614,814
+355.7%
0.03%
+350.0%
Q1 2022$4,997
-28.9%
134,914
-41.5%
0.01%
-33.3%
Q4 2021$7,024
+114.3%
230,814
+136.2%
0.01%
+125.0%
Q3 2021$3,277
-89.4%
97,714
-87.4%
0.00%
-89.7%
Q2 2021$30,971
+17.3%
776,414
+32.2%
0.04%
+18.2%
Q1 2021$26,410
-37.3%
587,414
-21.2%
0.03%
-28.3%
Q4 2020$42,142
-39.5%
745,348
-49.2%
0.05%
-34.3%
Q3 2020$69,617
-32.6%
1,467,167
-16.3%
0.07%
-21.3%
Q2 2020$103,349
+29.5%
1,752,867
+3.8%
0.09%
+14.1%
Q1 2020$79,828
-35.2%
1,688,411
-17.2%
0.08%
-17.9%
Q4 2019$123,159
+13.4%
2,038,711
+12.4%
0.10%
+3.3%
Q3 2019$108,617
-3.7%
1,813,011
+3.3%
0.09%
-7.1%
Q2 2019$112,814
+671.7%
1,755,311
+419.9%
0.10%
+1137.5%
Q2 2018$14,618
+45.6%
337,628
+48.3%
0.01%
-27.3%
Q1 2018$10,038
+139.5%
227,714
+176.3%
0.01%
+120.0%
Q2 2017$4,192
-66.7%
82,414
-73.7%
0.01%
-72.2%
Q1 2017$12,591
-41.4%
313,214
-30.3%
0.02%
-47.1%
Q4 2016$21,500
+113.5%
449,514
+63.6%
0.03%
+88.9%
Q3 2016$10,069
+136.1%
274,814
+50.1%
0.02%
+125.0%
Q2 2016$4,264
+77.2%
183,100
+208.2%
0.01%
+60.0%
Q1 2016$2,406
-71.3%
59,400
-56.1%
0.01%
-72.2%
Q4 2015$8,380135,3140.02%